Stewart M David, Behringer Richard R
Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
Methods Enzymol. 2010;477:145-51. doi: 10.1016/S0076-6879(10)77009-9.
Recognition sequences for the site-specific DNA recombinases Cre and FLP are commonly incorporated into gene targeting vectors for the purposes of removing selection markers or generating conditional alleles. Gene targeting vectors typically contain a positive selection marker, such as the neomycin resistance gene, flanked by loxP sites. Thus, the selection marker can be removed by breeding to a mouse strain which expresses Cre recombinase in its germ line. Conditional knockout vectors typically have one or more exons flanked by loxP sites and the positive selection marker flanked by FRT sites. Thus, the selection marker is removed with FLP recombinase and the knockout allele is generated in tissues expressing Cre recombinase. Because the generation of mice by gene targeting in embryonic stem (ES) cells is an expensive and time-consuming process, it is important to confirm that the recombination sites in your targeting vector are functional prior to electroporation of ES cells. This chapter describes a simple method for testing the functionality of loxP and FRT sites in vivo using Cre- or FLP-expressing bacteria.
位点特异性DNA重组酶Cre和FLP的识别序列通常被整合到基因靶向载体中,用于去除选择标记或产生条件性等位基因。基因靶向载体通常包含一个阳性选择标记,如新霉素抗性基因,两侧为loxP位点。因此,通过与在种系中表达Cre重组酶的小鼠品系杂交,可以去除选择标记。条件性敲除载体通常有一个或多个外显子两侧为loxP位点,阳性选择标记两侧为FRT位点。因此,用FLP重组酶去除选择标记,并在表达Cre重组酶的组织中产生敲除等位基因。由于通过在胚胎干细胞(ES)中进行基因靶向来生成小鼠是一个昂贵且耗时的过程,因此在将ES细胞电穿孔之前,确认靶向载体中的重组位点是否功能正常非常重要。本章描述了一种使用表达Cre或FLP的细菌在体内测试loxP和FRT位点功能的简单方法。